Harvest surgical site infection following coronary artery bypass grafting: Risk factors, microbiology, and outcomes

Division of Infectious Diseases, Department of Medicine, St. John Hospital and Medical Center, Detroit, MI, USA.
American journal of infection control (Impact Factor: 2.21). 05/2009; 37(8):653-7. DOI: 10.1016/j.ajic.2008.12.012
Source: PubMed


Our goals were to evaluate the risk factors predisposing to saphenous vein harvest surgical site infection (HSSI), the microbiology implicated, associated outcomes including 30-day mortality, and identify opportunities for prevention of infection.
All patients undergoing coronary artery bypass grafting (CABG) procedures from January 2000 through September 2004 were included. Data were collected on preoperative, intraoperative, and postoperative factors, in addition to microbiology and outcomes.
Eighty-six of 3578 (2.4%) patients developed HSSI; 28 (32.6%) of them were classified as deep. The median time to detection was 17 (range, 4-51) days. An organism was identified in 64 (74.4%) cases; of them, a single pathogen was implicated in 50 (78%) cases. Staphylococcus aureus was the most frequently isolated pathogen: 19 (38% [methicillin-susceptible S aureus (MSSA) = 12, methicillin-resistant S aureus (MRSA) = 7]). Gram-negative organisms were recovered in 50% of cases, with Pseudomonas aeruginosa predominating in 11 (22%) because of a single pathogen. Multiple pathogens were identified in 14 (22%) cases. The 30-day mortality was not significantly different in patients with or without HSSI. Multivariate analysis showed age, diabetes mellitus, obesity, congestive heart failure, renal insufficiency, and duration of surgery to be associated with increased risk.
Diabetes mellitus, obesity, congestive heart failure, renal insufficiency, and duration of surgery were associated with increased risk for HSSI. S aureus was the most frequently isolated pathogen.

42 Reads
  • Source
    • "The most frequently considered co-morbidity was diabetes, which was included in 13 adjusted analyses, and 85% of these reported a statistically significant association. Other co-morbidities for which significant adjusted associations were found included chronic obstructive pulmonary disease (COPD)[15–18], coronary heart disease[17], congestive heart failure[19], acute myocardial infarction[20], renal insufficiency[19], hypertension[21] and osteoporosis[17]. The relationship between increasing number of comorbidities and SSI was assessed in several studies. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Surgical site infection (SSI) complicates 2-5% of surgeries in the United States. Severity of SSI ranges from superficial skin infection to life-threatening conditions such as severe sepsis, and SSIs are responsible for increased morbidity, mortality, and economic burden associated with surgery. Staphylococcus aureus (S. aureus) is a commonly-isolated organism for SSI, and methicillin-resistant S. aureus SSI incidence is increasing globally. The objective of this systematic review was to characterize risk factors for SSI within observational studies describing incidence of SSI in a real-world setting. An initial search identified 328 titles published in 2002-2012; 57 were identified as relevant for data extraction. Extracted information included study design and methodology, reported cumulative incidence and post-surgical time until onset of SSI, and odds ratios and associated variability for all factors considered in univariate and/or multivariable analyses. Median SSI incidence was 3.7%, ranging from 0.1% to 50.4%. Incidence of overall SSI and S. aureus SSI were both highest in tumor-related and transplant surgeries. Median time until SSI onset was 17.0 days, with longer time-to-onset for orthopedic and transplant surgeries. Risk factors consistently identified as associated with SSI included co-morbidities, advanced age, risk indices, patient frailty, and surgery complexity. Thirteen studies considered diabetes as a risk factor in multivariable analysis; 85% found a significant association with SSI, with odds ratios ranging from 1.5-24.3. Longer surgeries were associated with increased SSI risk, with a median odds ratio of 2.3 across 11 studies reporting significant results. In a broad review of published literature, risk factors for SSI were characterized as describing reduced fitness, patient frailty, surgery duration, and complexity. Recognition of risk factors frequently associated with SSI allows for identification of such patients with the greatest need for optimal preventive measures to be identified and pre-treatment prior to surgery.
    PLoS ONE 12/2013; 8(12):e83743. DOI:10.1371/journal.pone.0083743 · 3.23 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Surgical wounds are usually closed by using either an interrupted or continuous suture using absorbable or non absorbable suture materials. Skin staples are an alternative to sutures and are usually used at the discretion of the surgeon. Skin wound closure with metallic clips is considered to be a fast and effective alternative to sutures. Furthermore, it is commonly believed that staples are less traumatic and may reduce wound complications. This makes the use of staples attractive as it may reduce the risk of postoperative wound complications. Surgical site infection (SSI) after saphenous vein graft harvesting is a postoperative complication that may occur in up to 18% of patients who undergo coronary artery bypass surgery (CABG). We considered the effects of using either staples or sutures for closing the skin after saphenous vein graft harvesting for CABG on rates of wound infection and wound dehiscence. We included four studies reporting on a total of 148 leg wounds closed with staples and 174 with sutures after vein graft harvesting in patients undergoing isolated CABG. There was no difference in leg wound infection rate or in leg wound dehiscence when wounds were closed with staples rather than with sutures.
    Cochrane database of systematic reviews (Online) 05/2010; 5(5):CD008057. DOI:10.1002/14651858.CD008057.pub2 · 6.03 Impact Factor
  • Source
    American journal of infection control 08/2010; 38(6):496-7. DOI:10.1016/j.ajic.2010.02.003 · 2.21 Impact Factor
Show more